Abstract:Objective: Colorectal cancer (CRC) is the third cause of expected cancer deaths both in men and women in the U.S. and the third most commonly diagnosed cancer in China Targeted therapy has been proven to improve overall survival for unresectable metastatic CRC. But the location of the primary tumor or the presence of various core driver gene mutations that confer resistance may limit the utility of targeted therapy. Therefore, it is of great significance to further elucidate novel mechanisms of invasion and metastasis of CRC and find potential novel therapeutic targets. Protein Kinase C Delta (PKC delta) plays an important role in various diseases, including tumors. In CRC, the function of PKC delta on proliferation and differentiation is mostly studied but various research results were reported. Therefore, the role of PKC delta in CRC needs to be further studied, especially in tumor invasion and metastasis in CRC which few studies have looked into.Methods: The expression of PRKCD was analyzed by the Genotype-Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA) databases and Immunohistochemical (IHC). Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA) enrichment analysis were used to explore the biological functions and pathways related to PRKCD. Lentivirus transfection was used to construct CRC cell lines with overexpression and knock-down of PKC delta or N-myc Downstream Regulated Gene 1 (NDRG1). Cell invasion and migration assay, wound healing assay were used to detect the function of PKC delta and NDRG1 in the invasion and migration of cells. Flow cytometry analysis was used to detect the influence of PKC delta on the CRC cell cycles .Immunofluorescence histochemistry ,Immunoprecipitation Assay and qPCR were used to detect the relationship of PKC delta and NDRG1. Xenograft model was used to verify the role of PKC delta in vivo.Results: PKC delta is overexpressed in CRC and could promote Epithelial-Mesenchymal Transition (EMT) and the invasion and migration of CRC in vitro. We confirmed that PKC delta and the tumor suppressor factor NDRG1 had a co-localization relationship in CRC. PKC delta inhibited NDRG1 transcription and protein expression. Overexpressing NDRG1 could inhibit the function of PKC delta in promoting tumor invasion and migration. PKC delta could regulate c-Myc, one transcription factor of NDRG1, to down-regulate NDRG1. In vivo, overexpressing PKC delta could promote xenograft growth and volume. Thus, our results showed that PKC delta reduced the expression of NDRG1 through c-Myc, promoting the invasion and migration of CRC through promoting EMT.Conclusion: The increased expression of PKC delta in CRC tumor tissue could promote the invasion and migration of tumor cells, and one of the mechanisms may be regulating c-Myc to inhibit the expression of NDRG1 and promote EMT.

PKCδ promotes the invasion and migration of colorectal cancer through c-myc/NDRG1 pathway

PKC delta promotes the invasion and migration of colorectal cancer through c-myc/NDRG1 pathway

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

Knockdown of NDRG1 Promote Epithelial-Mesenchymal Transition of Colorectal Cancer Via NF-κB Signaling.

Ndrg1 Regulates Filopodia-Induced Colorectal Cancer Invasiveness Via Modulating Cdc42 Activity

CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway

Keratin 80 promotes migration and invasion of colorectal carcinoma by interacting with PRKDC via activating the AKT pathway

Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells

The Expression Profiles and Clinical Significance of PKM2 and Notch1 in Colorectal Cancer

PKCι is a Promising Prognosis Biomarker and Therapeutic Target for Pancreatic Cancer.

MPC1 Deficiency Promotes CRC Liver Metastasis via Facilitating Nuclear Translocation of β -Catenin

PAK5 Facilitates the Proliferation, Invasion and Migration in Colorectal Cancer Cells

The Metastatic Suppressor NDRG1 Inhibits EMT, Migration and Invasion Through Interaction and Promotion of Caveolin-1 Ubiquitylation in Human Colorectal Cancer Cells

Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes

PKCε Phosphorylates MIIP and Promotes Colorectal Cancer Metastasis Through Inhibition of RelA Deacetylation

PAK1-dependent MAPK Pathway Activation is Required for Colorectal Cancer Cell Proliferation

DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2

B7-H4 expression is upregulated by PKCδ activation and contributes to PKCδ-induced cell motility in colorectal cancer

PICALM exerts a role in promoting CRC progression through ERK/MAPK signaling pathway

PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin αvβ6.

Multi-modal mechanisms of the metastasis suppressor, NDRG1: Inhibition of WNT/β-catenin signaling by stabilization of protein kinase Cα